The mitochondrial medicine community came together virtually for the Power Surge 2020 online event. This event is organized by the United Mitochondrial Disease Foundation (UMDF). Speakers and presenters provided thought-provoking discussions surrounding clinical trials, current topics facing the patient community in today’s unprecedented landscape.

Dr Magali Taiel, Chief Medical Officer, is invited to give an oral presentation  on LUMEVOQ® during the session “Clinical Trial Updates” on Friday 26 June, 2020.

  • Title:  LUMEVOQ®, Gene Therapy in Leber Hereditary Optic Neuropathy (LHON)
  • Session:  Clinical Trial Updates
  • Date:  Friday, June 26, 2020